Close

Drug Research

AI Accelerating Next-Generation GLP-1 Drug Discovery

The pharmaceutical industry is currently witnessing a significant shift in how metabolic therapies are conceptualized and developed, specifically through the integration of computational intelligence. The traditional methodology for identifying and validating glucagon-like peptide 1 receptor agonists has historically been...

Polymer Science Advancing Sustained Drug Delivery

The development of sustained-release drug delivery systems has transformed the treatment of chronic diseases by allowing for the controlled release of therapeutic agents over extended periods. This approach reduces the frequency of administration, improves patient compliance, and maintains drug...

Vascular Drug Targeting Enhancing Precision Delivery

The ability to deliver therapeutic agents specifically to diseased tissues while sparing healthy cells remains a central objective in pharmaceutical research. Traditional systemic drug delivery often results in suboptimal concentrations at the target site and significant off-target toxicity, which...

Prodrug Engineering Advancing Targeted Drug Delivery

The pharmaceutical industry continuously seeks methods to optimize the pharmacokinetic and pharmacodynamic properties of active pharmaceutical ingredients. Many promising drug candidates fail in development due to poor solubility, low permeability, or rapid metabolic clearance. Prodrug engineering advancing targeted drug...

Predictive Bioperformance Optimizing Drug Formulation

The pharmaceutical industry faces persistent challenges in the transition of drug candidates from discovery to clinical application. A primary obstacle is the accurate prediction of how a formulation will perform within the complex biological environment of the human body....

Bristol Myers Squibb Deploys Advanced Computing Cluster for Research

Pharmaceutical giant Bristol Myers Squibb has announced the deployment of its second NVIDIA DGX SuperPOD, an advanced computing cluster designed to accelerate the drug discovery pipeline. This new infrastructure, which utilizes the Vera Rubin architecture, represents a significant commitment...

Generative AI Advancing Novel Therapeutic Drug Discovery

The pharmaceutical sector is currently witnessing a profound shift in the methodology used to identify new chemical and biological entities. For decades, the discovery process relied heavily on high-throughput screening, where millions of existing molecules were tested against a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป